Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Luis Paulo Ugarte Pelaez, Yadith Karina Lopez-Garcia, Antonio Vega Mateos, Perla R. Colunga-Pedraza, Luz Tarin-Arzaga, Andres Gomez-De Leon, Olga Cantu, Jose Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 2364.

https://doi.org/10.1182/blood-2024-208836

Published: 2024

Journal Articles

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Antonio Vega Mateos, Héctor Alejandro Vaquera Alfaro, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Olga Cantu, Andres Gomez-De Leon, David Gomez-Almaguer, Luz Tarin-Arzaga, César Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza

Blood (2024) 144 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2024-208831

Published: 2024

Journal Articles

Lowering Conditioning Intensity in Fit Adolescents and Adults with Lymphoblastic Leukemia without Residual Disease Undergoing Transplantation: A Proof of Concept

Alexia Gonzalez, Ana Laura Varela Constantino, Nereida Méndez-Ramírez, Fernando J Medina-Olivares, Eli Fuentes-Chavez, Rosario Salazar-Riojas, César Homero Gutierrez-Aguirre, Olga Cantu, Perla Colunga-Pedraza, Luz Tarin-Arzaga, Xitlaly Judith Gonzalez Leal, Elías Eugenio Gonzalez-López, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 376.

https://doi.org/10.1182/blood-2024-208879

Published: 2024

Journal Articles

Optimizing Conditioning Intensity to Disease Burden in Adults with Acute Myeloid Leukemia Undergoing Transplantation: Results of a Prospective Multicenter Study

Ana L. Varela-Constantino, Michelle Morcos, Andres Noyola-Perez, Nereida Méndez-Ramírez, Eli Fuentes-Chavez, Rosario Salazar-Riojas, César Homero Gutierrez-Aguirre, Olga Cantu, Perla Rocio Colunga Pedraza, Luz Tarin-Arzaga, Xitlaly Judith Gonzalez Leal, Elías Eugenio Gonzalez-López, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2024-211711

Published: 2024

Journal Articles

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Alejandra De las Fuentes-Cepeda, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Michelle Morcos, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Antonio Vega Mateos, César Homero Gutierrez-Aguirre, Olga Cantu, Luz Tarin-Arzaga, Consuelo Mancías-Guerra, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles

Blood (2024) 144 (Supplement 1): 7299.

https://doi.org/10.1182/blood-2024-210921

Published: 2024

Journal Articles

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Gerardo Garcia-Salas, David Gomez-Almaguer, Carlos Reta-Cortéz, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, José Carlos Jaime-Pérez, César Homero Gutierrez-Aguirre, Luz Tarin-Arzaga, Perla Colunga-Pedraza, Olga Cantu, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 7119.

https://doi.org/10.1182/blood-2024-210532

Published: 2024

Journal Articles

Therapy Based on Attenuated Arsenic Trioxide Plus Low-Dose All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia. Is Less More?

Yadith Karina Lopez-Garcia, Edgar Ulises Coronado-Alejandro, Anna Cecilia Rodriguez, Gerardo Garcia-Salas, Antonio Vega Mateos, Ana Cristina Tejada Vasquez, Perla R. Rocio Colunga-Pedraza, Luz Tarin-Arzaga, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 6044.

https://doi.org/10.1182/blood-2024-208802

Published: 2024

Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Blood (2023) 142 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2023-185240

Published: 2023

Journal Articles

Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs

Eliezer Tomas Tomas Gomez Gomez, David Gomez Almaguer, Cesar Homero Gutierrez-Aguirre, Perla R.R. Colunga-Pedraza, Luz Tarin-Arzaga, Jose Carlos Jaime, Edgar Ulises Coronado, Fernando De La Garza, Estefania Guadarrama Rendon, Santiago Calzada Davila

Blood (2022) 140 (Supplement 1): 7710–7711.

https://doi.org/10.1182/blood-2022-163772

Published: 2022

Journal Articles

Danazol As First-Line Therapy for Myelodysplastic Syndromes

Perla Rocío Colunga-Pedraza, MD, Alejandra Garza-Ledezma, MD, Julia Colunga-Pedraza, Olga Cantu-Rodriguez, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Erika Cazares-Rendón, Erick J Rendón-Ramírez, MD, Cesar Homero Gutierrez-Aguirre, MD, Luz Tarin-Arzaga, MD, David Gomez-Almaguer, MD

Blood (2016) 128 (22): 5528.

https://doi.org/10.1182/blood.V128.22.5528.5528

Published: 2016

Journal Articles

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

David Gómez-Almaguer, Miguel A. Herrera-Rojas, José C. Jaime-Pérez, Andrés Gómez-De León, Olga G. Cantú-Rodríguez, César H. Gutiérrez-Aguirre, Luz Tarín-Arzaga, Jesús Hernández-Reyes, Guillermo J. Ruiz-Arguelles

Blood (2014) 123 (25): 3906–3908.

https://doi.org/10.1182/blood-2014-01-549360

Published: 2014

Journal Articles

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

David Gómez-Almaguer, Manuel Solano-Genesta, Luz Tarín-Arzaga, José Luis Herrera-Garza, Olga Graciela Cantú-Rodríguez, César Homero Gutiérrez-Aguirre, José Carlos Jaime-Pérez

Blood (2010) 116 (23): 4783–4785.

https://doi.org/10.1182/blood-2010-06-291831

Published: 2010

Journal Articles

Alemtuzumab in the Treatment of Steroid Refractory Acute Graft-Versus-Host Disease.

David Gomez-Almaguer, Guillermo Ruiz-Arguelles, Oscar Gonzalez-Llano, Olga G. Cantu, Cesar H. Gutierrez, Jose Carlos Jaime-Perez, Luz Tarin-Arzaga, Sergio Giralt

Blood (2006) 108 (11): 5294.

https://doi.org/10.1182/blood.V108.11.5294.5294

Published: 2006

NARROW

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Lowering Conditioning Intensity in Fit Adolescents and Adults with Lymphoblastic Leukemia without Residual Disease Undergoing Transplantation: A Proof of Concept

Optimizing Conditioning Intensity to Disease Burden in Adults with Acute Myeloid Leukemia Undergoing Transplantation: Results of a Prospective Multicenter Study

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Therapy Based on Attenuated Arsenic Trioxide Plus Low-Dose All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia. Is Less More?

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs

Danazol As First-Line Therapy for Myelodysplastic Syndromes

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

Alemtuzumab in the Treatment of Steroid Refractory Acute Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only